Trial Profile
A randomized, double blind, placebo controlled trial of rifaximin and neomycin in the Treatment of Constipation irritable bowel syndrome with Methane as a Biomarker on Breath Testing
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Dec 2015
Price :
$35
*
At a glance
- Drugs Neomycin (Primary) ; Rifaximin (Primary)
- Indications Irritable bowel syndrome
- Focus Therapeutic Use
- 08 Dec 2015 New trial record